article thumbnail

Why SAP ERP Makes Sense for Pharmaceutical Manufacturing

Navigator SAP

Legacy software systems no longer make sense for life sciences businesses, especially those in Pharmaceutical manufacturing. The problem is that complexity, regulation, and competition have changed how pharmaceutical and life sciences firms must do business. Other benefits include: 1.

article thumbnail

Govt plans major capital goods production push

CFO News

India is considering expanding its capital goods promotion scheme to include sectors like pharmaceuticals and textiles. Plans are also being considered to introduce new-age technologies beyond electric vehicles, batteries, and automobile manufacturing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma CFO Anthony Doyle Plans for Uncertainty

CFO

“If we tell you something, it’s because we believe it, and we’re neither sandbaggers nor are we going to lead with our chin and put out outrageous goals,” said Anthony Doyle, CFO of BioCryst Pharmaceuticals, when asked to describe how the publicly held biotech has established credibility by executing on projections.

CFO 65
article thumbnail

Alibaba Raises $1.3B For Push Into eCommerce Pharmaceutical Business

PYMNTS

Alibaba Health Information Technology plans to pump the $1.3 billion it raised in a secondary offering on the Hong Kong stock exchange to expand its eCommerce pharmaceutical business as it rides a wave of growth amid the coronavirus.

article thumbnail

What Are the Main Reasons for Pharma Companies to Implement ERP Systems?

Navigator SAP

For your pharmaceutical company to thrive in the current unstable market, you need to adopt new and advanced technologies that will streamline your daily operations. One of the latest technologies that you should have in your pharmaceutical company is an enterprise resource planning (ERP) system.

article thumbnail

Mubadala plans big deals in India's healthcare space

CFO News

Abu Dhabi's Mubadala Investment Company plans to expand in India's healthcare sector, seeking deals in the $200-500 million range. With a focus on pharmaceuticals, outsourced pharma services, and medtech, Mubadala aims to deploy capital meaningfully in India.

article thumbnail

ONGC plans to invest Rs 1 lakh cr to set up 2 petrochemical plants

CFO News

India's top oil and gas producer, ONGC, plans to invest approximately Rs 1 lakh crore in establishing two petrochemical plants to directly convert crude oil into high-value chemical products.